An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum

ProCAncer-I: a H2020-funded project aimed at developing a platform to support clinical decision making in prostate cancer through medical imaging and AI

Published on: October 29, 2020
Categories: News

The Medical Imaging Research Group at IDIBGI will receive funding to carry out the ProCAncer-I project starting late 2020. The project has been recently approved by the European Commission and will be funded under the H2020 framework program.

Read more

Source: https://www.idibgi.org/ca/actualitat/procancer-i-h2020-funded-project-aimed-developing-platform-support-clinical-decision

Highlights

ProCAncer-I at the IEEE EMBC 2023 in Sydney

ProCAncer-I at the IEEE EMBC 2023 in Sydney

Jul 28, 2023

Taking an innovative approach to applying artificial intelligence (AI) to medical imaging, Quibim is designing predictive panels to enable healthcare providers to improve patient outcomes.

Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer

Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer

Jul 24, 2023

Guerbet, a renowned global expert in medical imaging solutions and contrast media has announced the remarkable achievements of its teams in the PI-CAI Grand Challenge. This international challenge, organized by a consortium consisting of radiology opinion leaders,...

Stay in touch!